OTC Markets OTCPK - Delayed Quote USD
AIM ImmunoTech Inc. (AIMI)
0.0390
+0.0030
+(8.33%)
At close: 3:47:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
170
170
--
141
135
Cost of Revenue
31
31
--
--
850
Gross Profit
139
139
--
141
-715
Operating Expense
19,911
19,911
--
20,064
16,344
Operating Income
-19,772
-19,772
--
-19,923
-17,059
Net Non Operating Interest Income Expense
4,607
4,607
--
629
-67
Other Income Expense
-2,155
-2,155
--
-151
-2,001
Pretax Income
-17,320
-17,320
--
-19,445
-19,127
Net Income Common Stockholders
-17,320
-17,320
--
-19,445
-19,127
Diluted NI Available to Com Stockholders
-17,320
-17,320
--
-19,445
-19,127
Basic EPS
-0.31
-0.31
-0.60
-0.40
-0.40
Diluted EPS
-0.31
-0.31
-0.60
-0.40
-0.40
Basic Average Shares
56,016.8700
56,016.8700
48,585.4040
48,047.2880
47,339.9750
Diluted Average Shares
56,016.8700
56,016.8700
48,585.4040
48,047.2880
47,339.9750
Total Operating Income as Reported
-19,772
-19,772
--
-19,923
-18,838
Total Expenses
19,942
19,942
--
20,064
17,194
Net Income from Continuing & Discontinued Operation
-17,320
-17,320
--
-19,445
-19,127
Normalized Income
-16,769
-16,769
--
-17,804
-14,807
Interest Income
5,192
5,192
--
629
--
Interest Expense
585
585
--
--
67
Net Interest Income
4,607
4,607
--
629
-67
EBIT
-16,735
-16,735
-28,962
-19,923
-19,060
EBITDA
-16,489
-16,489
-28,724
-19,667
-18,285
Reconciled Cost of Revenue
31
31
--
--
850
Reconciled Depreciation
246
246
--
256
775
Net Income from Continuing Operation Net Minority Interest
-17,320
-17,320
--
-19,445
-19,127
Total Unusual Items Excluding Goodwill
-551
-551
--
-1,641
-4,320
Total Unusual Items
-551
-551
--
-1,641
-4,320
Normalized EBITDA
-15,938
-15,938
-28,942
-18,026
-13,965
12/31/2021 - 7/12/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARMP Armata Pharmaceuticals, Inc.
1.3200
+1.08%
DNTH Dianthus Therapeutics, Inc.
21.56
-1.42%
TTNP Titan Pharmaceuticals, Inc.
3.6999
+5.71%
DRMA Dermata Therapeutics, Inc.
0.7924
+13.20%
GON.DU Geron Corp
1.2240
+7.18%
HTD.MU Corcept Therapeutics Inc
56.94
+3.98%
BT3.BE Lineage Cell Therapeutics Inc
0.3720
+10.71%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
0M4.DU Mersana Therapeutics Inc
0.3381
+4.87%
PL3.F TuHURA Biosciences, Inc.
3.5800
+2.29%